Patents by Inventor Glendon E. French

Glendon E. French has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9808312
    Abstract: Methods for treating a network of organs including generating a map of at least a portion of the network of organs using a rendering system; selecting at least one treatment location within the luminal passageway of the network of organs; and applying an energy therapy to the treatment location to treat the smooth muscle tissue, where the energy therapy applied to the respective treatment location is defined by a plurality of parameters that are associated with a map. Such a system allows for historical or ideal treatment parameters to be identified, visually or otherwise to actual treatment locations. Also, control systems and methods for delivery of energy that may include control algorithms that prevent energy delivery if a fault is detected and may provide energy delivery to produce a substantially constant temperature at a delivery site. In some embodiments, the control systems and methods may be used to control the delivery of energy, such as radiofrequency energy, to body tissue, such as lung tissue.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: November 7, 2017
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Christopher J. Danek, William Wizeman, Timothy R. Dalbec, Glendon E. French, Michael D. Laufer
  • Publication number: 20160038230
    Abstract: Methods for treating a network of organs including generating a map of at least a portion of the network of organs using a rendering system; selecting at least one treatment location within the luminal passageway of the network of organs; and applying an energy therapy to the treatment location to treat the smooth muscle tissue, where the energy therapy applied to the respective treatment location is defined by a plurality of parameters that are associated with a map. Such a system allows for historical or ideal treatment parameters to be identified, visually or otherwise to actual treatment locations. Also, control systems and methods for delivery of energy that may include control algorithms that prevent energy delivery if a fault is detected and may provide energy delivery to produce a substantially constant temperature at a delivery site. In some embodiments, the control systems and methods may be used to control the delivery of energy, such as radiofrequency energy, to body tissue, such as lung tissue.
    Type: Application
    Filed: October 22, 2015
    Publication date: February 11, 2016
    Inventors: Christopher J. DANEK, William WIZEMAN, Timothy R. DALBEC, Glendon E. FRENCH, Michael D. LAUFER
  • Patent number: 9199091
    Abstract: Methods for treating a network of organs including generating a map of at least a portion of the network of organs using a rendering system; selecting at least one treatment location within the luminal passageway of the network of organs; and applying an energy therapy to the treatment location to treat the smooth muscle tissue, where the energy therapy applied to the respective treatment location is defined by a plurality of parameters that are associated with a map. Such a system allows for historical or ideal treatment parameters to be identified, visually or otherwise to actual treatment locations. Also, control systems and methods for delivery of energy that may include control algorithms that prevent energy delivery if a fault is detected and may provide energy delivery to produce a substantially constant temperature at a delivery site. In some embodiments, the control systems and methods may be used to control the delivery of energy, such as radiofrequency energy, to body tissue, such as lung tissue.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: December 1, 2015
    Assignee: Asthmatx, Inc.
    Inventors: Christopher J. Danek, William J. Wizeman, Timothy R. Dalbec, Glendon E. French, Michael D. Laufer
  • Publication number: 20100268222
    Abstract: Methods for treating a network of organs including generating a map of at least a portion of the network of organs using a rendering system; selecting at least one treatment location within the luminal passageway of the network of organs; and applying an energy therapy to the treatment location to treat the smooth muscle tissue, where the energy therapy applied to the respective treatment location is defined by a plurality of parameters that are associated with a map. Such a system allows for historical or ideal treatment parameters to be identified, visually or otherwise to actual treatment locations. Also, control systems and methods for delivery of energy that may include control algorithms that prevent energy delivery if a fault is detected and may provide energy delivery to produce a substantially constant temperature at a delivery site. In some embodiments, the control systems and methods may be used to control the delivery of energy, such as radiofrequency energy, to body tissue, such as lung tissue.
    Type: Application
    Filed: March 17, 2010
    Publication date: October 21, 2010
    Applicant: Asthmatx, Inc.
    Inventors: Christopher J. Danek, William J. Wizeman, Tim R. Dalbec, Glendon E. French, Michael D. Laufer
  • Patent number: 7708768
    Abstract: Methods for treating a network of organs including generating a map of at least a portion of the network of organs using a rendering system; selecting at least one treatment location within the luminal passageway of the network of organs; and applying an energy therapy to the treatment location to treat the smooth muscle tissue, where the energy therapy applied to the respective treatment location is defined by a plurality of parameters that are associated with a map. Such a system allows for historical or ideal treatment parameters to be identified, visually or otherwise to actual treatment locations. Also, control systems and methods for delivery of energy that may include control algorithms that prevent energy delivery if a fault is detected and may provide energy delivery to produce a substantially constant temperature at a delivery site. In some embodiments, the control systems and methods may be used to control the delivery of energy, such as radio frequency energy, to body tissue, such as lung tissue.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: May 4, 2010
    Assignee: Asthmatx, Inc.
    Inventors: Christopher J. Danek, William J. Wizeman, Tim R. Dalbec, Glendon E. French, Michael D. Laufer
  • Patent number: 7594925
    Abstract: Methods for treating a network of organs including generating a map of at least a portion of the network of organs using a rendering system; selecting at least one treatment location within the luminal passageway of the network of organs; and applying an energy therapy to the treatment location to treat the smooth muscle tissue, where the energy therapy applied to the respective treatment location is defined by a plurality of parameters that are associated with a map. Such a system allows for historical or ideal treatment parameters to be identified, visually or otherwise to actual treatment locations. Also, control systems and methods for delivery of energy that may include control algorithms that prevent energy delivery if a fault is detected and may provide energy delivery to produce a substantially constant temperature at a delivery site. In some embodiments, the control systems and methods may be used to control the delivery of energy, such as radiofrequency energy, to body tissue, such as lung tissue.
    Type: Grant
    Filed: April 21, 2006
    Date of Patent: September 29, 2009
    Assignee: Asthmatx, Inc.
    Inventors: Christopher J. Danek, William J. Wizeman, Tim R. Dalbec, Glendon E. French, Michael D. Laufer
  • Publication number: 20040073201
    Abstract: The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.
    Type: Application
    Filed: August 4, 2003
    Publication date: April 15, 2004
    Applicant: Broncus Technologies, Inc.
    Inventors: Joel D. Cooper, Bryan Loomas, Don Tanaka, Michael D. Laufer, David Thompson, James M. Davenport, Gary Kaplan, Dave Haugaard, Glendon E. French
  • Patent number: 6692494
    Abstract: The devices and methods disclosed herein are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having Chronic Obstructive Pulmonary Disease. More particularly, these devices and methods produce and to maintain collateral openings or channels through the airway wall so that expired air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs. The devices and methods also disclose locating and selecting a site for creation of a collateral opening.
    Type: Grant
    Filed: August 7, 2000
    Date of Patent: February 17, 2004
    Assignee: Broncus Technologies, Inc.
    Inventors: Joel D. Cooper, Bryan Loomas, Don Tanaka, Michael D. Laufer, David Thompson, James M. Davenport, Gary Kaplan, Dave Haugaard, Glendon E. French
  • Publication number: 20020042564
    Abstract: The devices and methods disclosed herein are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having Chronic Obstructive Pulmonary Disease. More particularly, these devices and methods produce and to maintain collateral openings or channels through the airway wall so that expired air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs. The devices and methods also disclose locating and selecting a site for creation of a collateral opening.
    Type: Application
    Filed: July 18, 2001
    Publication date: April 11, 2002
    Inventors: Joel D. Cooper, Bryan Loomas, Don Tanaka, Michael D. Laufer, David Thompson, Gary Kaplan, Dave Haugaard, Glendon E. French, Ed Roschak